Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-29

Clinical Trial Update: Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection [NA]

View source ↗

Summary

A multicenter prospective non-randomized study is evaluating 5-ALA–based photodynamic therapy for cervical LSIL in HPV 16/18–positive patients; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-aminolevulinic acid (5-ALA) photodynamic therapy (5-aminolevulinic acid)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: HPV-16/18, Photodynamic Therapy (PDT) | NA | Status: NOT_YET_RECRUITING